CORC

浏览/检索结果: 共954条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
FedED: Federated Learning via Ensemble Distillation for Medical Relation Extraction 会议论文
Online, 2020-11
作者:  Dianbo Sui;  Yubo Chen;  Jun Zhao;  Yantao Jia;  Yunantao Xie
收藏  |  浏览/下载:4/0  |  提交时间:2022/06/28
Design and Dynamic Simulation of Wheel/Track Transform Mobile Device 会议论文
Virtual, Shanghai, China, 2020-10-16-2010-10-18
作者:  Jing Leng;  Ming Chen;  Jianyu Xiao;  Jun Liu;  Jiaohua Xie
收藏  |  浏览/下载:24/0  |  提交时间:2021/06/29
Development of a Spherical Vacuum Window for Cryogenic Receiver 会议论文
Hangzhou, China, December 3, 2018 - December 6, 2018
作者:  Ma, Jun;  Xie, Lei;  Wu, Yang;  Wang, Kai;  Meng, Zeyu
收藏  |  浏览/下载:58/0  |  提交时间:2019/12/18
AAV-delivered IL-21 activates CD8+T-cells to clear HBV replicon plasmid and cccDNA in mice 会议论文
作者:  Deng, Qiang;  Shen, Zhongliang;  Liu, Jing;  Wu, Jingwen;  Zhu, Yuanfei
收藏  |  浏览/下载:62/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:45/0  |  提交时间:2019/12/05
Total-Body Parametric Imaging using Kernel and Direct Reconstruction on the uEXPLORER 会议论文
作者:  Zhang, Xuezhu;  Xie, Zhaoheng;  Berg, Eric;  Judenhofer, Martin;  Liu, Weiping
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/05
Evaluation on mirror seeing for AIMS solar telescope 会议论文
Xi'an, China, 2018-12-05
作者:  Xia, Yongbo;  Xie, Yongjun;  Wang, Peng;  Mao, Xiang-Long;  Song, Xuding
收藏  |  浏览/下载:46/0  |  提交时间:2019/04/02
Modeling and analysis of image rotation for the AIMS solar optical telescope 会议论文
Xi'an, China, 2018-12-05
作者:  Gong, Yinbing;  Xie, Yongjun;  Dong, Rongguang;  Mao, Xianglong;  Zhang, Tao
收藏  |  浏览/下载:54/0  |  提交时间:2019/04/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:37/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace